Susquehanna International Group
NMTC icon

Susquehanna International Group’s NeuroOne Medical Technologies NMTC Stock Holding History

Susquehanna International Group’s Portfolio NMTC Stock Details NMTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41.1K Buy
+13,520
New +$55.2K ﹤0.01% 12894
2025
Q4 		– Sell
-8,863
Closed -$47.3K – 13178
2025
Q3 		$47.3K Buy
+8,863
New +$43.4K ﹤0.01% 11877
2023
Q1 		– Sell
-14,321
Closed -$103K – 13178
2022
Q4 		$103K Buy
+14,321
New +$128K ﹤0.01% 10940
2022
Q2 		– Sell
-5,796
Closed -$38K – 13594
2022
Q1 		$38K Buy
+5,796
New +$70.2K ﹤0.01% 12427

Other funds holding NMTC

BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BA
Bard Associates Chicago, Illinois $451M AUM 66.6% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Susquehanna International Group's NMTC Position: Q2 2026 in Review

Susquehanna International Group opened a new position in NeuroOne Medical Technologies (NMTC) in Q2 2026: 13,520 shares worth $41.1K. The stake represents ﹤0.01% of the portfolio and ranks #12894 among its holdings. This is a return to the name: Susquehanna International Group previously reported a position in NMTC as recently as Q3 2025.

Susquehanna International Group first reported a position in NMTC in Q1 2022 and has held it in 4 quarters since. The position peaked at $103K in Q4 2022. 27 funds tracked by Wall St. Rank hold NMTC as of Q2 2026.

  • Susquehanna International Group held 13,520 shares of NeuroOne Medical Technologies worth $41.1K as of Q2 2026.
  • NeuroOne Medical Technologies was a new Susquehanna International Group position in Q2 2026.
  • NeuroOne Medical Technologies made up ﹤0.01% of Susquehanna International Group's portfolio in Q2 2026, its #12894 holding.
  • Susquehanna International Group first reported a position in NeuroOne Medical Technologies in Q1 2022 and has held it in 4 quarters since.
  • Susquehanna International Group's NeuroOne Medical Technologies position peaked at $103K in Q4 2022.
  • 27 funds tracked by Wall St. Rank held NeuroOne Medical Technologies as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.